HCPCS Level II J0190: Biperiden Lactate Injection, per 5 mg - OpenPayer

Summary & Overview

HCPCS Level II J0190: Biperiden Lactate Injection, per 5 mg

HCPCS Level II code J0190 describes the injectable medication biperiden lactate, billed per 5 mg unit. Biperiden is an anticholinergic agent commonly used to treat extrapyramidal symptoms and certain movement disorders; its injectable formulation is utilized when rapid parenteral administration is needed or when oral administration is not feasible. Nationally, accurate coding of injectable medications like J0190 matters for clinical documentation, billing compliance, and pharmacy-billing workflows.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context for use of biperiden lactate injection, the typical sites of service where the code is billed, and common billing modifiers applicable to parenteral drug administration. The publication outlines the elements clinicians and billing staff commonly review when submitting claims for injectable drugs — including unitization, route, and setting — and provides benchmarks and policy-relevant considerations where available. Data not available in the input is clearly noted. This summary equips coding managers, revenue cycle staff, and clinical leaders with a clear reference for interpreting and operationalizing HCPCS Level II code J0190 in a national payer context.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0190HCPCS Level IIinjectable medicationparenteral administrationbiperidendrug administrationmedical billingambulatory carehospital coding

Billing Code Overview

HCPCS Level II code J0190 denotes injection, biperiden lactate, per 5 mg. This code represents administration of the anticholinergic agent biperiden lactate formulated for injection, typically used for management of drug-induced extrapyramidal symptoms and certain movement disorders. The service type is parenteral medication administration (injectable drug). The typical site of service for use of this injectable medication is inpatient and outpatient clinical settings where parenteral medications are administered, including hospital inpatient units, emergency departments, outpatient infusion centers, and physician offices equipped for injections.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult presenting to an outpatient clinic, emergency department, or inpatient medical unit with acute extrapyramidal symptoms (drug-induced parkinsonism, acute dystonia, or severe extrapyramidal side effects) following recent antipsychotic or antiemetic therapy. The treating clinician (emergency physician, hospitalist, neurologist, or psychiatrist) assesses airway, breathing, and circulation, documents abnormal involuntary movements, and determines that parenteral anticholinergic therapy is indicated for rapid symptom relief. A 5 mg vial of biperiden lactate is prepared and administered intramuscularly or intravenously per facility protocol. Vital signs and neurologic status are rechecked after administration; additional supportive care or observation is provided. Documentation includes indication, medication name J0190 (biperiden lactate), dose administered, route, time, response to treatment, and any adverse reactions. Typical sites of service include outpatient clinics, emergency departments, inpatient wards, and observation units.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when administration required substantially greater resources or complexity than typical (document rationale).

HCPCS J2720: Protamine Sulfate Injection, per 10 mg

HCPCS-J1580-GENTAMICIN-INJECTION-UP-TO-80-MG

HCPCS Level II J1580: Gentamicin Injection, up to 80 mg

HCPCS-J3396-VERTEPORFIN-INJECTION-0-1-MG-PHOTODYNAMIC-THERAPY

HCPCS J3396: Verteporfin Injection, 0.1 mg

HCPCS-J2325-NESIRITIDE-INJECTION-0-1-MG

HCPCS Level II J2325: Injection of Nesiritide, 0.1 mg

HCPCS-J3394-LOVOTIBEGLOGENE-AUTOTEMCEL-INJECTION

HCPCS J3394: Injection, lovotibeglogene autotemcel, per treatment

HCPCS-J7313-FLUOCINOLONE-ACETONIDE-ILUVIEN-INTRAVITREAL-IMPLANT-0-01-MG

HCPCS Level II J7313: Fluocinolone Acetonide (Iluvien) Intravitreal Implant, 0.01 mg

HCPCS-J7120-RINGERS-LACTATE-INFUSION-UP-TO-1000-CC

HCPCS J7120: Ringers Lactate Infusion, up to 1000 cc

HCPCS-J0885-EPOETIN-ALFA-INJECTION-NON-ESRD-1000-UNITS

HCPCS J0885: Epoetin Alfa Injection, Non-ESRD, 1000 Units

HCPCS-J0458-AZTREONAM-AVIBACTAM-INJECTION

HCPCS J0458: Aztreonam/Avibactam Injection, 10 mg

HCPCS-J0132-INJECTION-ACETYLCYSTEINE-100MG-INJECTABLE-MEDICATION

HCPCS J0132: Injection, Acetylcysteine 100 mg

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`207R00000X`	Emergency Medicine	Emergency physicians commonly administer parenteral anticholinergics for acute dystonia.
`208000000X`	Family Medicine	Family physicians in outpatient or urgent care settings may administer intramuscular biperiden.
`2086S0102X`	Psychiatry	Psychiatrists manage antipsychotic adverse effects and may order or administer treatment.
`2084P0800X`	Neurology	Neurologists evaluate extrapyramidal syndromes and recommend parenteral anticholinergics when indicated.
`363A00000X`	Hospitalist/Internal Medicine	Hospitalists commonly manage inpatient adverse drug reactions and administer therapy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G21.0`	Acute drug-induced dystonia	Primary indication for parenteral anticholinergic therapy such as biperiden.
`G21.9`	Drug-induced secondary parkinsonism, unspecified	Biperiden may be used to treat acute worsening of parkinsonian symptoms from medication exposure.
`T43.591A`	Adverse effect of antipsychotics and neuroleptics, initial encounter	Documents adverse reaction to antipsychotic agents prompting treatment with `J0190`.
`T43.592A`	Adverse effect of other psychostimulants, initial encounter	Used when extrapyramidal effects arise from other psychotropic medications requiring anticholinergic therapy.
`R25.1`	Tremor, unspecified	May be recorded when tremor is present as part of extrapyramidal symptomatology responding to anticholinergic treatment.
`F10.288`	Other alcohol-induced movement disorders	Included when substance-induced movement disorders present and anticholinergic therapy is used symptomatically.
`G25.9`	Movement disorder, unspecified	Coded when a specific movement disorder diagnosis is pending and parenteral symptomatic therapy is provided.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used for billing the act of intramuscular administration of `J0190` when the injection is given in an outpatient or clinic setting.
`96374`	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance/drug	Used when `J0190` is administered as an intravenous push.
`99406`	Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes	Data not available in the input.
`99283`	Emergency department visit, moderate complexity	Often billed for the ED evaluation that leads to administration of parenteral biperiden for acute dystonic reactions.
`99223`	Initial hospital care, high severity	Billed when inpatient admission results and the patient requires comprehensive initial hospital evaluation prior to or after administration.
`36415`	Collection of venous blood by venipuncture	May be performed if laboratory testing is needed to evaluate alternative causes or medication levels around the time of treatment.

OpenPayer